GHK-Cu / KPV 50mg/10mg Blend

Comprehensive Laboratory Profile

The integration of tissue-regenerative peptides with targeted anti-inflammatory analogs provides modern institutions with an advanced tool for mapping complex repair pathways. The GHK-Cu KPV 50/10mg blend is engineered specifically for researchers documenting the transition from acute inflammatory response to extracellular matrix (ECM) restoration.

Synthesized in the USA to the highest industry standards, this high-potency compound delivers the analytical precision required by modern facilities. Utilizing the GHK-Cu KPV 50/10mg blend ensures your facility obtains definitive data free from the inconsistencies found in standard-grade laboratory materials.

Biochemical Profile: The Regenerative Synergy

This formulation merges the signaling properties of Copper Peptide (GHK-Cu) with the potent immunomodulatory effects of the tripeptide KPV (Lysine-Proline-Valine). GHK-Cu acts as a primary signaling molecule for structural protein synthesis, while KPV works to stabilize the micro-environment by inhibiting pro-inflammatory cytokine activity.

In an isolated laboratory environment, the GHK-Cu within the GHK-Cu KPV 50/10mg blend coordinates the repair response, while the KPV component minimizes the cellular damage often associated with rapid inflammatory cascades. This provides a clean, controlled model for investigating optimal tissue healing.

Mechanism of Action

When introduced to cellular models, this compound exhibits a dual-action response. KPV penetrates the cell membrane to downregulate NF-κB signaling, preventing the activation of inflammatory pathways that can delay repair.

Concurrently, the GHK-Cu component stimulates fibroblasts to synthesize collagen and elastin, replenishing the structural matrix. Researchers use this blend to monitor how the suppression of inflammation (via KPV) allows for a more accelerated and orderly deployment of the regenerative signaling (via GHK-Cu).

Primary Research Applications

The synergistic potential of this blend makes it a cornerstone tool for regenerative medicine and dermatological research:

• Inflammatory Modulation Assays: Mapping the kinetic response of cell cultures to KPV-mediated cytokine inhibition.

• Extracellular Matrix (ECM) Modeling: Evaluating the rate of collagen and elastin synthesis under combined signaling.

• Mucosal Barrier Repair Studies: Establishing baseline data for cellular resilience in simulated high-stress environments.

• Structural Integrity Research: Using the GHK-Cu KPV 50/10mg blend to document the influence of anti-inflammatory signaling on the success of tissue remodeling.

Purity and Quality Assurance

At Ion Peptides, we recognize that anomalous data from impure materials compromises research outcomes. Every batch of our GHK-Cu KPV 50/10mg blend is subjected to rigorous third-party analytical testing.

We utilize High-Performance Liquid Chromatography (HPLC) to verify a purity threshold of >99.0%. This absolute precision ensures the complete isolation of both active peptides from residual synthesis solvents.

Furthermore, Mass Spectrometry (MS) is employed to verify the precise molecular weight and structural integrity of the complex. By securing your GHK-Cu KPV 50/10mg supply through our USA synthesis network, you guarantee materials that meet the highest echelons of analytical compliance.

Storage and Reconstitution

The GHK-Cu KPV 50/10mg vial is supplied as a lyophilized (freeze-dried) powder to ensure stability.

• Storage: Keep vials in a climate-controlled environment at or below -20°C. Protected from light and moisture, the powder remains stable for up to 36 months.

• Reconstitution: Utilize sterile bacteriostatic water.

  1. Allow the vial to reach room temperature before opening.

  2. Introduce the diluent slowly, letting it flow down the interior glass wall.

  3. Do not vortex or shake. Allow the GHK-Cu KPV 50/10mg compound to dissolve via gentle, rotational swirling.

  4. Store reconstituted solution at 2°C to 8°C and utilize within standard laboratory protocol timelines.